Stock Comparison

ONC vs REGN

BeiGene, Ltd. and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

ONC

BeiGene, Ltd.

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$29.04B

$66.35B

P/E (TTM)

63.3

15.5

Forward P/E

45.5

14.1

Price/Sales

5.1

4.5

Price/Book

6.1

2.1

EV/EBITDA

29.7

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

8.94%

29.60%

Operating Margin

16.50%

20.70%

Return on Equity

12.40%

14.50%

Return on Assets

5.96%

6.13%

Growth (YoY)

Revenue Growth

35.50%

19.00%

Earnings Growth

16971.00%

-7.20%

Price & Risk

Beta

0.5

0.2

52-Week High

$385.22

$818.90

52-Week Low

$239.25

$516.07

Analyst Target

$412.35

$833.31

Compare ONC and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.